Calumet Specialty Products Partners reports upgraded earnings expectations driven by renewable fuel pricing, though regulatory uncertainty and negative equity pose risks to refining margins. Investors
Concerns over potential U.S. diesel export bans and geopolitical risks are driving focus toward integrated oil and gas majors, specifically profiling Calumet Specialty Products Partners, DT Midstream,
Two Seas Capital LP reduced its stake in Calumet Specialty Products Partners by 20.2% in Q3. Despite a quarterly loss, the company reported a 40.8% revenue increase and trades near its 52-week high.
Calumet Specialty Products Partners stock rose 1.36% after securing a $600 million credit facility and DOE loan guarantee for its MaxSAF renewable fuel expansion. Analysts maintain a consensus "Hold"
H.C. Wainwright raised its price target for Calumet Specialty Products Partners to USD 75.00 following increased financing commitments. The company secured additional working capital for its specialty
Calumet Specialty Products Partners will attend the Barclays 40th Annual Energy-Power Conference on September 10, 2026, for investor meetings. The Indianapolis-based firm manufactures specialty brande
Calumet Inc (CLMT-Q) provides real-time stock data and financial analysis for the NASDAQ-listed company. Calumet Specialty Products Partners specializes in manufacturing and marketing specialty brande
Calumet Specialty Products Partners submitted a Form 4 filing on September 29, per Investing.com. The report lists stock symbol CLMT with minimal details beyond the filing's existence.
Calumet Specialty Products Partners plans to increase sustainable aviation fuel capacity to 200 million gallons by 2028. Analysts rate the stock as a "Hold" due to high valuation and reliance on gover
Calumet Specialty Products Partners holds a consensus 'Hold' rating from seven brokerages with an average price target of $51.75. Despite $1.45 billion in quarterly revenue, the company posted an adju
State Street Corp increased its holdings in Calumet, Inc. by 12.7%, acquiring an additional 390,906 shares valued at approximately $125 million, despite the company missing quarterly earnings estimate
Calumet Inc shares fell 3.6% to $54.38 due to overvaluation concerns despite year-to-date gains. The company holds a GF Score of 52, indicating average performance with significant valuation risks and
Calumet Specialty Products Partners stock dropped 3.62% despite a $34 million DOE loan and $600M financing expansion for renewable fuels, reporting Q2 revenue of $1.45 billion against an adjusted loss
Calumet Specialty Products expanded its credit facility to $600 million and secured a $34 million DOE loan for renewable fuels. This financing aims to ease liquidity pressures while supporting the com
Calumet Inc. increased its asset-based loan commitments to $600 million while subsidiary Montana Renewables secured the final $34 million DOE loan for its MaxSAF renewable fuel project.
Calumet Specialty Products Partners shares reached an all-time high of $58.44, marking a nearly 210% increase over the past year despite concerns of being overvalued.
Calumet Specialty Products Partners stock reached a 52-week high of $54.72, surging over 200% annually despite mixed Q2 2026 results. S&P Global Ratings upgraded the firm to 'B-' alongside updated pri
Wellington Management Group LLP reduced its stake in Calumet, Inc. by 2.3% in Q2, selling 19,076 shares while retaining holdings worth $29.2 million despite mixed analyst sentiment.
HC Wainwright raised its price target for Calumet Specialty Products Partners to $75, citing a 40.8% year-over-year revenue increase. Despite missing earnings expectations, the firm maintains a buy ra
Analysts assigned Calumet, Inc. a 'Hold' rating with a $48 target despite 40.8% revenue growth. The company missed earnings, though institutional investors significantly increased their positions.
Calumet Specialty Products Partners stock hit a 52-week high of $51.51, driven by strong Q2 results and performance in specialty oils and renewable fuels.
S&P Global Ratings upgraded Calumet Specialty Products Partners' credit rating to "B-", citing strong first-half 2026 earnings and performance in specialty oils and renewable fuels. The stable outlook
UBS raised its price target for Calumet Specialty Products Partners to $47 from $26, maintaining a Neutral rating. This update reflects an improved analyst outlook on the oil and gas refining company.
Calumet Specialty Products Partners announced plans to attend the Barclays 40th Annual Energy-Power Conference on September 10, 2026, for investor meetings. The company manufactures specialty branded
Calumet Inc shares fell 3.5% to $47.28, though GuruFocus assesses the stock as significantly overvalued by 159.4%. The company remains unprofitable with negative cash flow and notable insider selling.
Calumet Inc shares rose 5.1%, but GuruFocus rates the stock significantly overvalued at $50.81 against an intrinsic value of $18.23. Concerns over unprofitability and insider selling advise investor c
Calumet Specialty Products Partners stock reached a new 52-week high of $49.17, boosting market cap to $4.31 billion despite a Q2 adjusted EPS loss. TD Cowen raised its price target to $40 while maint
Calumet Specialty Products Partners reported increased Q2 sales but a wider first-half net loss driven by profitability pressures. Its investment strategy hinges on shifting to renewables and specialt
Bank of America increased its stake in Calumet Specialty Products Partners by 65.1% in Q1. Calumet reported a 40.8% revenue increase but missed earnings estimates with an adjusted loss.
Calumet Specialty Products Partners faces mixed valuation signals as Strait of Hormuz tensions drive up Brent crude prices. Analysts debate whether the stock is overvalued at $47.19 due to debt and re
Calumet Specialty Products Partners shares surged to a 12-month high of $45.55, driven by a 40.8% year-over-year revenue increase to $1.45 billion, despite reporting an adjusted loss of $1.09 per shar
Calumet Specialty Products Partners stock reached a 52-week high of $45.20 following strong Q2 2026 revenue of $1.44 billion. Analysts forecast profitability for the year despite recent losses and an
Calumet Specialty Products Partners shares climbed nearly 12% to $44.22, marking its highest closing level since November 2007 with significant year-to-date growth.
Calumet, Inc. received a consensus Hold rating after missing earnings expectations, despite a 40.8% revenue increase and insider sales driving a 5.7% share price drop.
Calumet Specialty Products Partners reported quarterly earnings missing consensus estimates by $1.16 per share despite a 40.8% revenue increase to $1.45 billion. Following the announcement, shares fel
Calumet, Inc. (CLMT) stock data and financial history are detailed in this overview. The company specializes in specialty chemicals and renewable fuels, offering analyst insights for investors.
Renaissance Technologies LLC initiated a new investment in Calumet Specialty Products Partners, purchasing 391,800 shares worth approximately $14.1 million, despite mixed financial sentiment.
Calumet Inc. shares rose 1.01% to $44.19, holding a $3.85 billion market cap. Analysts rate the renewable fuel and specialty products maker a Buy despite weak fundamentals, setting a target price of $
Healthcare of Ontario Pension Plan Trust Fund increased its stake in Calumet, Inc. by 107% in Q1 to $3.5 million, though analysts maintain a 'Hold' rating amid mixed insider signals.
HC Wainwright issued a Q2 2027 earnings forecast of $0.19 per share for Calumet Specialty Products Partners, maintaining a Buy rating with a $60 price target. This outlook surpasses the broader analys
Rangeley Capital LLC reduced its stake in Calumet Specialty Products Partners by 79.6% to approximately $1.9 million in Q1. Calumet reported a quarterly EPS loss despite a 3.6% year-over-year revenue
Lombard Odier Asset Management cut its position in Calumet Specialty Products Partners by 40.5% to $2.14 million in Q1, following wider-than-expected losses and insider selling.
Calumet Specialty Products Partners reached a new 52-week high of $44.17 despite missing EPS estimates, while analysts remain divided with a consensus Hold rating and $36.75 price target.
AnalystConsensusTarget raised Calumet Specialty Products Partners' fair value to $41.08, citing improved margins and revenue growth. The company is actively deleveraging by redeeming senior notes to r
Calumet Specialty Products Partners redeemed $100 million of senior notes to improve its capital structure and reduce interest burdens. The move supports the company's transition toward renewables whi
Calumet Specialty Products Partners stock hit a 52-week high of $41.39; despite a Q1 earnings miss, revenue beat expectations and $100M in senior notes will be redeemed.
Calumet, Inc. secured a consensus Hold rating with a $36.75 price target following an EPS miss and revenue beat. Insider selling occurred alongside a marginal share price rise.
Calumet Specialty Products Partners reached a new 52-week high trading near $39.50 despite missing earnings expectations with a negative EPS. Analyst sentiment remains mixed, with HC Wainwright raisin
Calumet Specialty Products Partners stock reached a 52-week high of $38.88 despite analyst forecasts of losses and a recent Q1 earnings miss. The company also announced plans to redeem $100 million in
Calumet Specialty Products Partners will redeem $100 million in senior notes at 102.438% of principal to strengthen its balance sheet. Shares rose 4.36% following the announcement of reduced interest
ChemBrief